These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7552910)
1. Applying patient outcomes and pharmacoeconomics in patient care. Proceedings of a conference. Boston, Massachusetts, September 1994. Am J Health Syst Pharm; 1995 Jul; 52(14 Suppl 3):S1-5. PubMed ID: 7552910 [No Abstract] [Full Text] [Related]
2. [The 2nd Annual Conference of the Israeli Society for Pharmacoeconomics and Outcomes Research (ISPOR-Israel), September 2008]. Tal O Harefuah; 2009 Aug; 148(8):554-6. PubMed ID: 19899262 [No Abstract] [Full Text] [Related]
3. The outcomes of patient care. Gouveia WA; Chapman MM Am J Health Syst Pharm; 1995 Jul; 52(14 Suppl 3):S11-5. PubMed ID: 7552911 [No Abstract] [Full Text] [Related]
4. Proceedings of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Second Latin America Conference. September 2009. Brazil. Value Health; 2011; 14(5 Suppl 1):S1-150. PubMed ID: 21998840 [No Abstract] [Full Text] [Related]
6. Health care reform: is the process the outcome? Gibson E; Lyles A Clin Ther; 2009 Sep; 31(9):2014-7. PubMed ID: 19843491 [No Abstract] [Full Text] [Related]
7. Survey of ACCP members regarding health economics and outcomes assessment. Paladino JA Pharmacotherapy; 1996; 16(2):267-70. PubMed ID: 8820471 [TBL] [Abstract][Full Text] [Related]
8. What is next for pharmacoeconomics and outcomes research in Asia? Doherty J; Kamae I; Lee KK; Li H; Li SC; Liu GG; Tarn YH; Yang BM Value Health; 2004; 7(2):118-32. PubMed ID: 15164802 [TBL] [Abstract][Full Text] [Related]
9. The role of colleges of pharmacy in meeting the pharmacoeconomic needs of the pharmaceutical industry: a conference report. Draugalis JR; Coons SJ Clin Ther; 1994; 16(3):523-37; discussion 522. PubMed ID: 7923318 [TBL] [Abstract][Full Text] [Related]
10. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference. Postma MJ Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):305-7. PubMed ID: 19670989 [TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness research and healthcare reform: topics of the day. DeKoven M; Goldberg E; Powers J Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):395-7. PubMed ID: 21831018 [TBL] [Abstract][Full Text] [Related]
12. Drug therapy: safety, effectiveness, and economics. Brandys J Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340 [TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomics: is a drug worth its cost? Marwick C JAMA; 1994 Nov; 272(18):1395. PubMed ID: 7933406 [No Abstract] [Full Text] [Related]
14. The United Kingdom guidelines for the economic evaluation of medicines. Lovatt B Med Care; 1996 Dec; 34(12 Suppl):DS179-81. PubMed ID: 8969324 [No Abstract] [Full Text] [Related]
15. Pharmacoeconomics: drug pricing's new guise. Fox JL Biotechnology (N Y); 1995 May; 13(5):435-6. PubMed ID: 9634784 [No Abstract] [Full Text] [Related]
16. Pharmacoeconomics and managed care: methodologic and policy issues. Luce BR Med Decis Making; 1998; 18(2 Suppl):S4-11. PubMed ID: 9566461 [No Abstract] [Full Text] [Related]
17. Pharmacoeconomics and outcomes research. Bootman JL Am J Health Syst Pharm; 1995 Jul; 52(14 Suppl 3):S16-9. PubMed ID: 7552912 [No Abstract] [Full Text] [Related]
18. International Society for Pharmacoeconomics and Outcomes Research (ISPOR)4th Annual European Conference. 11-13 November 2001. Cannes, France. Abstracts. Value Health; 2001; 4(6):401-540. PubMed ID: 11727724 [No Abstract] [Full Text] [Related]
19. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective. Thwaites R; Townsend RJ Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645 [TBL] [Abstract][Full Text] [Related]
20. Incorporating pharmacoeconomic principles into hospital pharmacy practice. Gouveia WA; Bungay KM Top Hosp Pharm Manage; 1994 Jan; 13(4):31-7. PubMed ID: 10130681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]